Skip to content

Addiction: all studies

Page 470 of 857: studies 4,691 to 4,700 of 8,563, newest first. Back to the addiction overview

Research

Interplay Between the Salience and the Default Mode Network in a Social-Cognitive Task Toward a Close Other

Frontiers in Psychiatry February 7, 2022 Cátia Ribeiro da Costa, Jose M. Soares, Patrícia Oliveira-Silva et al.

Social cognition relies on two main subsystems to construct the understanding of others, which are sustained by different social brain networks. One of these social networks is the default mode network (DMN) associated with the socio-cognitive subsystem (i.e., mentalizing), and the other is the salience network (SN) associated with the socio-affective route (i.e., empathy). The DMN and the SN...

Psilocybin: Characterization of the Metastable Zone Width (MSZW), Control of Anhydrous Polymorphs, and Particle Size Distribution (PSD)

ACS Omega February 7, 2022 Robert B. Kargbo, Alexander M. Sherwood, Poncho Meisenheimer et al. 5 citations

Psilocybin, a serotonergic agonist, was granted a "breakthrough therapy" status by the Food and Drug Administration for clinical trials involving major depressive disorder and treatment-resistant depression. The direct phosphorylation of psilocin to psilocybin that uses a fast crystallization associated with a kinetically controlled process resulted in a smaller particle size distribution....

DOI: 10.1021/acsomega.1c06708 (opens in new tab) Psilocybin Nucleation Metastability Recrystallization geology +7

Ketamine for the acute treatment of severe suicidal ideation: double blind, randomised placebo controlled trial

British medical journal February 2, 2022 M. Abbar, C. Demattei, Wissam El-Hage et al. 172 citations

Abstract Objective To confirm the rapid onset anti-suicidal benefits of ketamine in the short term and at six weeks, overall and according to diagnostic group. Design Prospective, double blind, superiority, randomised placebo controlled trial. Setting Seven French teaching hospitals between 13 April 2015 and 12 March 2019. Eligibility criteria for participants Aged 18 or older with current...

Adverse effects of psychedelics: From anecdotes and misinformation to systematic science.

Journal of Psychopharmacology February 2, 2022 Anne K. Schlag, Jacob S. Aday, Iram Salam et al. 319 citations

BACKGROUND: Despite an increasing body of research highlighting their efficacy to treat a broad range of medical conditions, psychedelic drugs remain a controversial issue among the public and politicians, tainted by previous stigmatisation and perceptions of risk and danger. OBJECTIVE: This narrative review examines the evidence for potential harms of the classic psychedelics by separating...

DOI: 10.1177/02698811211069100 (opens in new tab) Full text (opens in new tab) Psychedelic research Psychedelics study Risk assessment Risk evaluation +4

Reward produces learning of a consciously inaccessible feature.

British Journal of Psychology February 2022 Xue Dong, Mingxia Zhang, Bo Dong et al.

Reward has a significant impact on behaviour and perception. Most past work in associative reward learning has used perceptually distinct visual cues to associate with different reward values. Thus, it remains unknown to what extent the learned bias towards reward-associated stimuli depends on consciousness of the apparent differences between stimuli. Here, we resolved this issue by using an...

DOI: 10.1111/bjop.12518 (opens in new tab) Full text (opens in new tab) Attention Consciousness Eye of origin Inter-ocular suppression +1

Neural correlates of consciousness and related disorders: From phenotypic descriptors of behavioral and relative consciousness to cortico-subcortical circuitry.

Neuro-Chirurgie February 2022 J-J Lemaire, B Pontier, R Chaix et al.

We report a review of medical aspects of the consciousness. The behavioral dimension, phenotypic descriptors, relative consciousness and neural correlates of consciousness and related disorders were addressed successively in a holistic and chronological approach. Consciousness is relative, specific to each individual across time and space. Historically defined as the perception of the self and...

Acute effects of oral delta-9-tetrahydrocannabinol (THC) on autonomic cardiac activity and their relation to subjective and anxiogenic effects.

Psychophysiology February 2022 Elisa Pabon, Frederica Rockwood, Greg J Norman et al.

Cannabis is the most commonly used psychotropic drug in the United States, after alcohol. Despite its apparent sedative and calming effects, cannabis and its main psychoactive constituent, ∆9 -tetrahydrocannabinol (THC) can produce serious adverse effects including tachycardia and anxiety. These effects can be especially pronounced in women, who remain underrepresented in clinical cannabinoid...

DOI: 10.1111/psyp.13955 (opens in new tab) Full text (opens in new tab) Cannabis Autonomic Delta-9-tetrahydrocannabinol Heart rate variability +1

The Effectiveness of Mindfulness-Based Cognitive Therapy in Primary Care and the Role of Depression Severity and Treatment Attendance

Mindfulness February 1, 2022 Matilde Elices, Víctor Pérez Sola, Adrián Pérez-aranda et al.

Abstract Objectives Evidence suggests the efficacy of mindfulness-based cognitive therapy (MBCT) to prevent depression relapse and decrease depressive symptoms during the acute phase. However, the effectiveness of MBCT in real-world heterogeneous samples treated in clinical health settings, including primary care, has received little attention. This study had two aims: (1) to evaluate the...

THE EFFECTS OF MDMA-ASSISTED THERAPY ON ALCOHOL AND SUBSTANCE USE IN A PHASE 3 TRIAL FOR TREATMENT OF SEVERE PTSD

Drug and Alcohol Dependence February 1, 2022 Christopher R. Nicholas, Julie B. Wang, Allison R. Coker et al. 67 citations

Background Post-traumatic stress disorder (PTSD) is commonly associated with alcohol and substance use disorders (ASUD). A randomized, placebo-controlled, phase 3 trial demonstrated the safety and efficacy of MDMA-assisted therapy (MDMA-AT) for the treatment of severe PTSD. This analysis explores patterns of alcohol and substance use in patients receiving MDMA-AT compared to placebo plus...

Rewarding and reinforcing effects of two dissociative-based new psychoactive substances, deschloroketamine and diphenidine, in mice.

Pharmacology, Biochemistry, and Behavior February 1, 2022 Jin Mook Kim, Boreum Han, Hyun Kyu Min et al. 4 citations

Dissociative-based new psychoactive substances (NPSs) are increasingly available through the Internet, and public health problems related to the recreational use of these substances have been increasing globally. Two such NPSs are deschloroketamine and diphenidine, which are primarily used recreationally as ketamine substitutes. However, there is little scientific evidence to describe the...

DOI: 10.1016/j.pbb.2022.173333 (opens in new tab) Full text (opens in new tab) Conditioned place preference Dependence liability Deschloroketamine Diphenidine +2